Shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) shot up 1.1% during mid-day trading on Friday . The stock traded as high as $3.84 and last traded at $3.70, with a volume of 281,307 shares traded. The stock had previously closed at $3.74.

The stock has a 50 day moving average of $3.99 and a 200-day moving average of $4.00. The stock’s market cap is $120.32 million.

An institutional investor recently bought a new position in VBI Vaccines, Inc. – stock. Cambridge Investment Research Advisors Inc. bought a new position in shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,433,100 shares of the biopharmaceutical company’s stock, valued at approximately $3,497,000. Cambridge Investment Research Advisors Inc. owned about 6.09% of VBI Vaccines, Inc. – at the end of the most recent reporting period.

VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.